HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Susumu Suzuki Selected Research

atuveciclib

12/2018Cyclin-dependent kinase 9 as a potential specific molecular target in NK-cell leukemia/lymphoma.
1/2017Cyclin-dependent kinase 9 is a novel specific molecular target in adult T-cell leukemia/lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Susumu Suzuki Research Topics

Disease

37Neoplasms (Cancer)
05/2024 - 06/2003
13Myocardial Infarction
02/2019 - 09/2005
12Cardiovascular Diseases (Cardiovascular Disease)
12/2018 - 01/2013
10Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
01/2020 - 10/2009
7Chronic Renal Insufficiency
02/2019 - 12/2015
6Squamous Cell Carcinoma of Head and Neck
05/2024 - 06/2020
6Coronary Artery Disease (Coronary Atherosclerosis)
03/2018 - 02/2013
5Thrombosis (Thrombus)
12/2017 - 01/2013
5Death (Near-Death Experience)
03/2017 - 04/2014
5Anorexia
02/2006 - 07/2004
4Neoplasm Metastasis (Metastasis)
12/2023 - 11/2015
4Head and Neck Neoplasms (Head and Neck Cancer)
08/2023 - 11/2017
4Infections
01/2020 - 03/2007
4Proteinuria
09/2019 - 01/2015
4Body Weight (Weight, Body)
01/2017 - 07/2004
4Weight Loss (Weight Reduction)
05/2008 - 07/2004
3Squamous Cell Neoplasms (Squamous Cell Cancer)
05/2024 - 11/2017
3Leukemia
01/2024 - 12/2018
3Lymphatic Metastasis
12/2023 - 12/2022
3Pancreatic Neoplasms (Pancreatic Cancer)
12/2023 - 12/2021
3Carcinoma (Carcinomatosis)
12/2022 - 08/2020
3Type 2 Diabetes Mellitus (MODY)
05/2020 - 10/2004
3Hypertension (High Blood Pressure)
01/2020 - 01/2007
3Obesity
01/2020 - 07/2004
3Neointima
12/2019 - 01/2013
3Atherosclerosis
03/2017 - 01/2013
3Diabetes Mellitus
01/2007 - 03/2003
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2024 - 05/2021
2Acute Promyelocytic Leukemia
01/2024 - 01/2024
2Breast Neoplasms (Breast Cancer)
12/2023 - 12/2022
2Atrial Fibrillation
06/2023 - 09/2017
2Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2021 - 01/2020
2Prostatic Neoplasms (Prostate Cancer)
10/2019 - 07/2019
2Heart Failure
01/2019 - 09/2014
2Left Ventricular Dysfunction
01/2019 - 03/2013
2ST Elevation Myocardial Infarction
12/2017 - 01/2015
2Hemorrhage
09/2017 - 06/2017
2Inflammation (Inflammations)
04/2017 - 07/2014
2Stable Angina
02/2017 - 08/2013
2Acute Coronary Syndrome
02/2017 - 01/2017
2Atherosclerotic Plaque (Atheroma)
01/2017 - 08/2013
2Albuminuria
03/2016 - 07/2014
2Peripheral Arterial Disease
02/2016 - 07/2014
2Diabetic Neuropathies (Diabetic Neuropathy)
01/2013 - 02/2009
2Morbid Obesity
05/2008 - 10/2007

Drug/Important Bio-Agent (IBA)

9Insulin (Novolin)FDA Link
01/2014 - 03/2003
7Proteins (Proteins, Gene)FDA Link
12/2020 - 01/2011
6Hormones (Hormone)IBA
10/2019 - 07/2004
6omega-Chloroacetophenone (Mace)IBA
03/2017 - 01/2013
4AntigensIBA
05/2024 - 10/2008
4Cisplatin (Platino)FDA LinkGeneric
08/2023 - 11/2017
4mogamulizumabIBA
12/2022 - 10/2015
4Tryptophan (L-Tryptophan)FDA Link
12/2020 - 06/2015
4Monoclonal AntibodiesIBA
01/2020 - 08/2009
4LipidsIBA
12/2017 - 01/2013
4Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
07/2014 - 06/2005
4Glucose (Dextrose)FDA LinkGeneric
01/2014 - 10/2004
3Fluorouracil (Carac)FDA LinkGeneric
01/2023 - 11/2017
3Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2019
3AntibodiesIBA
01/2021 - 06/2005
3Immune Checkpoint InhibitorsIBA
06/2020 - 03/2016
3AutoantibodiesIBA
01/2019 - 04/2004
3Protein Isoforms (Isoforms)IBA
06/2018 - 12/2017
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2018 - 12/2017
3HDL CholesterolIBA
02/2018 - 02/2015
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
02/2017 - 02/2015
3Neuropeptide YIBA
02/2006 - 08/2004
3Serotonin (5 Hydroxytryptamine)IBA
02/2006 - 08/2004
3CytokinesIBA
07/2005 - 07/2004
2Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2024 - 01/2024
2Phosphotransferases (Kinase)IBA
01/2024 - 05/2004
2Phenobarbital (Luminal)FDA Link
12/2023 - 01/2020
2folfirinoxIBA
12/2023 - 12/2021
2GemcitabineFDA Link
12/2022 - 12/2021
2130-nm albumin-bound paclitaxelIBA
12/2022 - 12/2021
2venetoclaxIBA
10/2021 - 12/2020
2Messenger RNA (mRNA)IBA
10/2021 - 01/2020
2Cyclin-Dependent Kinase 9IBA
12/2018 - 01/2017
2atuveciclibIBA
12/2018 - 01/2017
2NivolumabIBA
11/2018 - 03/2016
2PPAR gammaIBA
01/2018 - 03/2007
2Therapeutic UsesIBA
01/2018 - 07/2013
2Neoplasm Antigens (Tumor Antigens)IBA
11/2017 - 05/2014
2Cilostazol (Pletal)FDA LinkGeneric
02/2016 - 04/2014
2Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2016 - 07/2014
2Telomerase (Telomerase Reverse Transcriptase)IBA
05/2014 - 09/2002
2EpitopesIBA
02/2014 - 03/2011
2IndicanIBA
03/2013 - 02/2013
2MetalsIBA
01/2013 - 01/2013

Therapy/Procedure

27Therapeutics
01/2024 - 03/2003
11Percutaneous Coronary Intervention
01/2020 - 08/2013
10Stents
01/2020 - 01/2009
9Immunotherapy
09/2022 - 10/2012
6Drug Therapy (Chemotherapy)
12/2023 - 03/2014
6Drug-Eluting Stents
01/2020 - 01/2009
5Renal Dialysis (Hemodialysis)
04/2017 - 12/2015
5Gastric Bypass (Roux-en-Y Gastric Bypass)
01/2011 - 07/2004
3Pancreaticoduodenectomy
12/2023 - 12/2022
3Neoadjuvant Therapy
12/2023 - 12/2021
3Adjuvant Chemotherapy
12/2022 - 11/2015